Year Founded
2016
Ownership
Public
Employees
~133
Stage
Preclinical
Modalities
Molecular diagnostics

Nautilus Biotechnology General Information

Development stage company creating a platform technology for quantifying and unlocking the complexity of the proteome. Has not yet commercialized any products.

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Seattle, Washington
United States

Drug Pipeline

No pipeline data available

For full access to Nautilus Biotechnology's pipeline data

Book a demo

Key Partnerships

Genentech, Amgen, The University of Texas MD Anderson Cancer Center, Abcam

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Nautilus Biotechnology Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Nautilus Biotechnology's complete valuation and funding history, request access »

Nautilus Biotechnology Investors

Cercano Management (formerly Vulcan Capital)
Investor Type: Venture Capital
Holding: Minority
Perceptive Advisors
Investor Type: Venture Capital
Holding: Minority
Defy Partners
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 8 investors. Get the full list »